Integrative proteomics reveals an increase in non-degradative ubiquitylation in activated CD4+ T cells
Despite gathering evidence that ubiquitylation can direct non-degradative outcomes, most investigations of ubiquitylation in T cells have focused on degradation. Here, we integrated proteomic and transcriptomic datasets from primary mouse CD4 + T cells to establish a framework for predicting degrada...
Gespeichert in:
Veröffentlicht in: | Nature immunology 2019-06, Vol.20 (6), p.747-755 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Despite gathering evidence that ubiquitylation can direct non-degradative outcomes, most investigations of ubiquitylation in T cells have focused on degradation. Here, we integrated proteomic and transcriptomic datasets from primary mouse CD4
+
T cells to establish a framework for predicting degradative or non-degradative outcomes of ubiquitylation. Di-glycine remnant profiling was used to reveal ubiquitylated proteins, which in combination with whole-cell proteomic and transcriptomic data allowed prediction of protein degradation. Analysis of ubiquitylated proteins identified by di-glycine remnant profiling indicated that activation of CD4
+
T cells led to an increase in non-degradative ubiquitylation. This correlated with an increase in non-proteasome-targeted K29, K33 and K63 polyubiquitin chains. This study revealed over 1,200 proteins that were ubiquitylated in primary mouse CD4
+
T cells and highlighted the relevance of non-proteasomally targeted ubiquitin chains in T cell signaling.
Oliver and colleagues use di-glycine remnant profiling in combination with whole-cell proteomics and transcriptomics to identify ubiquitylated proteins and predict degradative or non-degradative outcomes of ubiquitylation in activated primary mouse CD4
+
T cells. |
---|---|
ISSN: | 1529-2908 1529-2916 |
DOI: | 10.1038/s41590-019-0381-6 |